Progress the Highlight of Second International Mesothelioma Symposium: Financial News - Yahoo! Finance
Progress the Highlight of Second International Mesothelioma Symposium: Financial News - Yahoo! Finance: "Press ReleaseSource: Mesothelioma Applied Research Foundation
Progress the Highlight of Second International Mesothelioma Symposium
Wednesday October 19, 5:00 am ET
SANTA BARBARA, Calif., Oct. 19 /PRNewswire/ -- Fresh evidence of progress in the diagnosis and treatment of an aggressive asbestos-related cancer was the highlight of the Second International Symposium on Malignant Mesothelioma last week. Long considered lethal, meso is a tumor that invades the linings of the lungs, abdomen, heart or testicles. The Mesothelioma Applied Research Foundation (MARF) organizes the annual symposium, held this year in Las Vegas Nevada, to unite the meso community and focus on curing the disease.
ADVERTISEMENT
Advances in detection, multimodal treatment, gene therapy, and immunotherapy were among the topics that thrilled the audience. Ann Ferrero, whose mother was diagnosed with meso a year ago, admitted that 'Last year my entire family reeled from the shock.' The information presented at the symposium, however, left her feeling -- in her own words, 'moved, grateful ... and, dare I say ... hopeful!'
The symposium is unique in that it brings together doctors, researchers, advocates, meso patients and families to learn from each other and exchange research results, study findings, and review progress. MARF Director of Communications, and 4 year pleural meso survivor, Klaus Brauch, stated that 'the most important sign of progress for me was that we are now talking about second-line treatments, something of great interest to those of us concerned about recurrences. A few years ago just surviving first-line treatment was an achievement.' MARF, which has awarded over two million dollar"
Progress the Highlight of Second International Mesothelioma Symposium
Wednesday October 19, 5:00 am ET
SANTA BARBARA, Calif., Oct. 19 /PRNewswire/ -- Fresh evidence of progress in the diagnosis and treatment of an aggressive asbestos-related cancer was the highlight of the Second International Symposium on Malignant Mesothelioma last week. Long considered lethal, meso is a tumor that invades the linings of the lungs, abdomen, heart or testicles. The Mesothelioma Applied Research Foundation (MARF) organizes the annual symposium, held this year in Las Vegas Nevada, to unite the meso community and focus on curing the disease.
ADVERTISEMENT
Advances in detection, multimodal treatment, gene therapy, and immunotherapy were among the topics that thrilled the audience. Ann Ferrero, whose mother was diagnosed with meso a year ago, admitted that 'Last year my entire family reeled from the shock.' The information presented at the symposium, however, left her feeling -- in her own words, 'moved, grateful ... and, dare I say ... hopeful!'
The symposium is unique in that it brings together doctors, researchers, advocates, meso patients and families to learn from each other and exchange research results, study findings, and review progress. MARF Director of Communications, and 4 year pleural meso survivor, Klaus Brauch, stated that 'the most important sign of progress for me was that we are now talking about second-line treatments, something of great interest to those of us concerned about recurrences. A few years ago just surviving first-line treatment was an achievement.' MARF, which has awarded over two million dollar"
posted by Chris Placitella | 8:09 AM
0 Comments:
Post a Comment
<< Home